Failure to Treat Life-Threatening Ventricular Tachyarrhythmias in Contemporary Implantable Cardioverter–Defibrillators: Implications for Strategic Programming

BACKGROUND: In clinical trials, manufacturer-specific, strategic programming of implantable cardioverter–defibrillators (ICDs), including faster detection rates, reduces unnecessary therapy but permits therapy for ventricular tachycardia/ventricular fibrillation (VF). Present consensus recommends a...

Descripción completa

Detalles Bibliográficos
Autores principales: Thøgersen, Anna Margrethe, Larsen, Jacob Moesgaard, Johansen, Jens Brock, Abedin, Moeen, Swerdlow, Charles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610568/
https://www.ncbi.nlm.nih.gov/pubmed/28916511
http://dx.doi.org/10.1161/CIRCEP.117.005305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610568/
https://www.ncbi.nlm.nih.gov/pubmed/28916511
http://dx.doi.org/10.1161/CIRCEP.117.005305

Ejemplares similares